Table 2: Effects of isoquercetin and or estrogen on dopamine, norepinephrine and serotonine levels in ovariectomized rats.


Treatment  Parameter  


Dopamine (ng/g wet tissue)  Nor epinephrine (ng/g wet tissue)  5HT (ng/g wet tissue)  
Control  610 ± 10.2  78 ± 2.1  121 ± 10.1 
Sham  650 ± 11.3  68 ± 3.3  205 ± 8.2 
OVX  390 ^{ a, b } ± 9.1  42 ^{ a, b } ± 2.3  101 ^{ a, b } ± 9.1 
OVX + Isoqurcitrin  480 ^{ a, b, c } ± 6.8  58 ^{ a, b, c } ± 4.1  135 ^{ a, b, c } ± 7.6 
OVX + Estrogen  495 ^{ a, b, c } ± 12.1  56 ^{ a, b, c } ± 2.8  168 ^{ a, b, c, d } ± 5.8 
OVX + Isoqurcitrin + Estrogen  560 ^{ a, b, c, d, e } ± 13.4  66 ^{ a, b, c, d, e } ± 4.9  178 ^{ a, b, c, d } ± 3.7 


Data presented are means ± SEM. (n = 8).
aP < 0.05; significantly different from control group. bP < 0.05; significantly different from OVX group. ANOVA followed by TukeyKramer post hoc test . a: significant difference from control group. b: significant difference from sham group. c: significant difference from ovx (ovariectomized) non treated group. d: significant difference from ovx (ovariectomized) isoquercetin treated group. e: significant difference from ovx (ovariectomized) estrogen treated group. 